moderately significantp< 0.05
For RBC count ( Figure 1 A), a highly significant difference between the cancer-negative and LSIL groups ( p< 0.0001) and a moderately significant difference between the LSIL and adenocarcinoma groups ( p< 0.05) were observed, suggesting potential anemia in patients with LSIL that is frequently observed in patients receiving chemo-/radiotherapies for cervical cancer ( 19 ).